Abstract:Importance: Hypertension is a leading cause of cardiovascular disease. The results were previously reported of a trial of home blood pressure (BP) telemonitoring and pharmacist management intervention in which the interventions stopped after 12 months. There were significantly greater reductions in systolic BP (SBP) in the intervention group than in the usual care group at 6, 12, and 18 months (-10.7, -9.7, and -6.6 mm Hg, respectively).Objectives: To examine the durability of the intervention effect on BP through 54 months of follow-up and to compare BP measurements performed in the research clinic and in routine clinical care.Design, Setting, and Participants: Follow-up of a cluster randomized clinical trial among 16 primary care clinics and 450 patients with uncontrolled hypertension in a large health system from March 2009 to November 2015.Interventions: A home BP telemonitoring intervention with pharmacist management or usual care.Main Outcomes and Measures: Change from baseline to 54 months in SBP and diastolic BP (DBP) measured as the mean of 3 measurements obtained at each research clinic visit.Results: Among 450 patients, 228 (mean [SD] age, 62.0 [11.7] years; 54.8% male) were randomized to the telemonitoring intervention and 222 (mean [SD] age, 60.2 [12.2] years; 55.9% male) to usual care. Research clinic BP measurements were obtained from 326 of 450 (72.4%) study patients at the 54-month follow-up visit, including 162 (mean [SD] age, 62.0 [11.1] years; 54.9% male) randomized to the telemonitoring intervention and 164 (mean [SD] age, 60.0 [11.2] years; 57.3% male) to usual care. Routine clinical care BP measurements were obtained from 439 of 450 (97.6%) study patients at 6248 visits during the follow-up period. Based on research clinic measurements, baseline mean SBP was 148 mm Hg in both groups. In the intervention group, mean SBP at 6-, 12-, 18-, and 54-month follow-up was 126.7, 125.7, 126.9, and 130.6 mm Hg, respectively. In the usual care group, mean SBP at 6-, 12-, 18-, and 54-month follow-up was 136.9, 134.8, 133.0, and 132.6 mm Hg, respectively. The differential reduction by study group in SBP from baseline to 54 months was -2.5 mm Hg (95% CI, -6.3 to 1.2 mm Hg; P = .18). The DBP followed a similar pattern, with a differential reduction by study group from baseline to 54 months of -1.0 mm Hg (95% CI, -3.2 to 1.2 mm Hg; P = .37). The SBP and DBP results from routine clinical measurements suggested significantly lower BP in the intervention group for up to 24 months.Conclusions and Relevance: This intensive intervention had sustained effects for up to 24 months (12 months after the intervention ended). Long-term maintenance of BP control is likely to require continued monitoring and resumption of the intervention if BP increases.Trial Registration: ClinicalTrials.gov Identifier: NCT00781365.

Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study

Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta‐Analysis

Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension

OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION

Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial

A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension

Effects of Comprehensive Lifestyle Modification on Diet, Weight, Physical Fitness, and Blood Pressure Control: 18-Month Results of a Randomized Trial

Effect of Adapted Mindfulness Training in Participants With Elevated Office Blood Pressure: The MB-BP Study: A Randomized Clinical Trial

ANTIHYPERTENSIVE TREATMENT OF MASKED HYPERTENSION GUIDED BY AMBULATORY BLOOD PRESSURE MONITORING: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Body Weight Loss with Phentermine Alone Versus Phentermine and Fenfluramine with Very-Low-calorie Diet in an Outpatient Obesity Management Program: a Retrospective Study

Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication

Weight reduction and pharmacologic treatment in obese hypertensives

P146 EFFECT OF HOME BLOOD PRESSURE TELE-MONITORING PATHWAY WITH PHARMACIST CASE MANAGEMENT TO SUPPORT PATIENTS DISCHARGED FROM EMERGENCY DEPARTMENT WITH ASYMPTOMATIC HYPERTENSION: A STUDY PROTOCOL FOR MULTICENTRE RANDOMIZED CONTROLLED TRIAL (TEC4HOME-BP)

Effects of Adapted Mindfulness Training on Interoception and Adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet: The MB-BP Randomized Clinical Trial

A Randomized Cross-over Study on the Blood Pressure Lowering Effect of the Combined Passive Head-Up and -Down Movement with Device-Guided Slow Breathing.

BASELINE CHARACTERISTICS IN A RANDOMIZED PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF THE SIX PLANT EXTRACTS COMBINATION TOTUM-854 ON BLOOD PRESSURE MANAGEMENT: THE INSIGHT STUDY

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP): Rational, Design, and Baseline Characteristics for the Main Trial.

Topiramate added to metformin for obesity control in women with polycystic ovary syndrome: a randomized clinical trial

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

OFFICE, HOME AND AMBULATORY BLOOD PRESSURE CONTROL IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK – RESULTS FROM BP-PROACTION BG

EVALUATING THE PROGNOSTIC VALUE OF DIFFERENT BLOOD PRESSURE PHENOTYPES ON AMBULATORY BLOOD PRESSURE MONITORING IN WOMEN